Evaluation of the vaccine formulation with recombinant protein CP01850 and fish oil from Rhamdia quelen: an alternative and innovative adjuvant against Corynebacterium pseudotuberculosis
Archives of Microbiology · 2025
DOI: 10.1007/s00203-025-04550-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, 2025. Verfasst von Nicole Ramos Scholl und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas (UFPel), Camp…. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Bacterial Vaccines, Fish Oils, Corynebacterium pseudotuberculosis. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Fish oils contain bioactive molecules such as omega-3, -6, and - 9 fatty acids, which modulate immune responses. The oil of Rhamdia quelen (RQO) was characterized, revealing 62.86% unsaturated fatty acids. To assess its potential as an adjuvant in caseous lymphadenitis (CLA) vaccines, Balb/c mice were divided into four groups: saline (G1), rCP01850 + AddaVax (G2), rCP01850 + RQO (G3), and RQO alone (G4). Only G3 achieved significant protection (4/10, p = 0.0047), while G1 and G4 showed none. Humoral analysis showed that G3 had the second highest antibody production (total IgG, IgG2b, IgG3), surpassed only by G2. At day 42, IgG1 and IgG2a levels were statistically equivalent between G2 and G3. Importantly, G3 was the only group with elevated IFN-γ and IL-17 (p = 0.0001), indicating a robust cellular immune response. These findings suggest that RQO is a safe and promising natural adjuvant capable of enhancing both humoral and cellular responses, improving vaccine efficacy against CLA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas (UFPel), Campus Universitário S/N, Prédio 19, Pelotas, RS, 96010-900, Brazil.
- Laboratório de Biotecnologia do Câncer, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil.
- Laboratório de Lipidômica e Bio-Orgânica, Centro de Ciências Químicas, Farmacêuticas e de Alimentos, UFPel, Pelotas, RS, 96010-900, Brazil.
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas (UFPel), Campus Universitário S/N, Prédio 19, Pelotas, RS, 96010-900, Brazil. sibel…
Zitieren
APA
Scholl, N. R., Nogueira, T. B., Alves, M. S. D., Pegoraro, H. G., Sousa, F. S. S., Seixas, F. K., Collares, T., Bueno, D. T., de PereiraPereira, C. M., & Borsuk, S. (2025). Evaluation of the vaccine formulation with recombinant protein CP01850 and fish oil from Rhamdia quelen: an alternative and innovative adjuvant against Corynebacterium pseudotuberculosis. Archives of Microbiology. https://doi.org/10.1007/s00203-025-04550-6
Vancouver
Scholl NR, Nogueira TB, Alves MSD, Pegoraro HG, Sousa FSS, Seixas FK, et al. Evaluation of the vaccine formulation with recombinant protein CP01850 and fish oil from Rhamdia quelen: an alternative and innovative adjuvant against Corynebacterium pseudotuberculosis. Archives of Microbiology. 2025. doi:10.1007/s00203-025-04550-6
BibTeX
@article{Scholl2025,
author = {Scholl, Nicole Ramos and Nogueira, Tallyson Barbosa and Alves, Mirna Samara Dié and Pegoraro, Henrique Gonçalves and Sousa, Fernanda Severo Sabedra and Seixas, Fabiana Kommling and Collares, Tiago and Bueno, Danielle Tapia and de PereiraPereira, Cláudio Martin and Borsuk, Sibele},
title = {Evaluation of the vaccine formulation with recombinant protein CP01850 and fish oil from Rhamdia quelen: an alternative and innovative adjuvant against Corynebacterium pseudotuberculosis},
journal = {Archives of Microbiology},
year = {2025},
doi = {10.1007/s00203-025-04550-6}
}
EUVIMED